Post-earnings recap
Reported
Wed, Oct 29, 2025
EPS actual
$2.26
EPS est.
$2.30
EPS surprise
-1.74%
1-day move
-3.31%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Bio-Rad's earnings report indicates a slight miss on EPS, which contributed to a 3.31% drop in stock price. The lack of revenue data and guidance may raise concerns among investors about the company's future performance. Management's defensive tone suggests they are facing challenges in the market, which could impact growth moving forward.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.26 | N/A | -1.74% |
| Revenue | N/A | N/A | N/A |
Management expressed concerns about current market conditions impacting performance. They highlighted efforts to manage costs but did not provide specific future guidance.
Management noted ongoing challenges in the market.
They emphasized a focus on cost management and efficiency.
There was no specific guidance provided for future quarters.